Xeris Biopharma Reports Third Quarter 2023 Financial Results

Go back to Xeris Biopharma Reports Third Quarter 2023 Financial Results
(NASDAQ: XERS) Delayed: 8.70 +0.10 (1.16%)
Previous Close $8.60    52 Week High
Open $8.61    52 Week Low
Day High $8.81    P/E N/A 
Day Low $8.54    EPS
Volume 1,562,901